IR vs TERN · P/E 49, rev $7.24B vs $6.12B cap
Ingersoll Rand Inc (IR) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
IR currently screens at market cap $28.27B and trailing P/E 48.8. TERN currently screens at market cap $6.12B.
Not investment advice. Open the IR and TERN stock pages for the full models.
Not investment advice.